XJPX
4931
Market cap263mUSD
Jul 10, Last price
2,012.00JPY
1D
-0.25%
1Q
-3.36%
IPO
29.64%
Name
Shinnihonseiyaku Co Ltd
Chart & Performance
P/E
16.69
P/S
1.04
EPS
120.55
Div Yield, %
2.58%
Shrs. gr., 5y
-0.43%
Rev. gr., 5y
4.05%
Revenues
41.14b
+2.74%
Net income
2.55b
-8.62%
CFO
4.69b
+123.65%
Dividend
Sep 29, 202657 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shinnihonseiyaku Co., Ltd. is a Japanese-headquartered company, established in 1992, that specializes in providing cosmetics, pharmaceuticals, and health foods both domestically and in international markets. The company's operations are structured into Mail Order, Direct Store Sales/Wholesale, and Overseas Sales divisions. Its product portfolio includes skincare lines sold under the Perfect One and Perfect One Focus brands, as well as a variety of pharmaceutical products targeting different diseases and symptoms. Shinnihonseiyaku reaches its customers through multiple channels, including eight company-owned retail stores, the NOIN cosmetics mail order application, and various online e-commerce platforms. The firm, previously known as Shinnihonliving Co., Ltd., officially adopted its current name in April 2002, and maintains its corporate headquarters in Fukuoka City.
IPO date
Jun 27, 2019
Employees
302
Domiciled in
JP
Incorporated in
JP
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||